Abbott Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Abbott Laboratories' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Abbott Laboratories in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
110.57112.05113.53
Details
Intrinsic
Valuation
LowReal ValueHigh
100.83125.50126.98
Details
Naive
Forecast
LowNext ValueHigh
114.13115.61117.09
Details
14 Analysts
Consensus
LowTarget PriceHigh
125.00140.33157.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Abbott Laboratories. Your research has to be compared to or analyzed against Abbott Laboratories' peers to derive any actionable benefits. When done correctly, Abbott Laboratories' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Abbott Laboratories.

Abbott Laboratories Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Abbott Laboratories and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Abbott and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Abbott Laboratories does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Abbott Laboratories Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Abbott Stock performing well and Abbott Laboratories company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Abbott Laboratories' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
COST 1.60  0.07  0.04  0.16  2.62  0.0446 (1.65)  3.68 (2.39)  14.73 
BBBY 7.44  1.41  0.21  0.63  6.67  0.15 (8.98)  23.55 (9.94)  54.03 
ECL 1.57  0.04  0.03  0.14  1.80  0.0306 (1.70)  4.01 (3.35)  10.05 
ATAI 3.63  0.48  0.13  0.37  4.15  0.12 (3.90)  8.15 (7.86)  20.29 
MRK 0.96 (0.04) (0.08)  0.02  1.22 (0.08) (1.00)  2.11 (2.50)  6.96 
CAT 1.77 (0.15)  0.00 (0.01)  0.00 (0.05)  0.00  3.82 (4.35)  11.37 
HD 1.25  0.09  0.05  0.21  1.72  0.05 (1.35)  2.75 (2.60)  7.58 
DIS 1.87  0.14  0.09  0.21  1.76  0.08 (2.21)  3.98 (3.76)  7.34 
IBM 1.08  0.00 (0.03)  0.10  1.68 (0.034) (1.01)  2.09 (2.47)  7.86 

Cross Equities Net Income Analysis

Compare Abbott Laboratories and related stocks such as Costco Wholesale, Bed Bath Beyond, Ecolab Inc, Atai Life Sciences, Merck Company, Caterpillar, Home Depot, Walt Disney, and International Business Net Income Over Time
Select Fundamental

2010201120122013201420152016201720182019202020212022
COSTBBB3.7 B3.7 B3.7 B3.7 B3.7 B3.7 BBB2.1 B2.7 B
BBBYBBBB(137.2 M)(137.2 M)(137.2 M)(137.2 M)(137.2 M)(559.6 M)(559.6 M)(559.6 M)(617.6 M)
ECL462.5 M462.5 M703.6 M967.8 M1.2 BB1.2 B1.5 B1.4 B1.6 B(1.2 B)1.1 B976.9 M
ATAI(14.1 M)(14.1 M)(14.1 M)(14.1 M)(14.1 M)(14.1 M)(14.1 M)(14.1 M)(14.1 M)(14.1 M)(169.8 M)(167.8 M)(181.1 M)
MRK6.3 B6.3 B6.2 B4.4 B11.9 B4.4 B3.9 B2.4 B6.2 B9.8 B7.1 B13 B10.9 B
CAT4.9 B4.9 B5.7 B3.8 B2.5 B2.5 B(67 M)754 M6.1 B6.1 BB6.5 B5.6 B
HD6.3 B6.3 B6.3 B6.3 B6.3 B11.2 B11.2 B11.2 B11.2 B11.2 B16.4 B16.4 B15.4 B
DIS4.8 B9.4 B9.4 B9.4 B9.4 B9.4 BBBBBBB7.5 B
IBM15.9 B15.9 B16.6 B16.5 B12 B13.2 B11.9 B5.8 B8.7 B9.4 B5.6 B5.7 B7.7 B

Abbott Laboratories and related stocks such as Costco Wholesale, Bed Bath Beyond, Ecolab Inc, Atai Life Sciences, Merck Company, Caterpillar, Home Depot, Walt Disney, and International Business Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Abbott Laboratories financial statement analysis. It represents the amount of money remaining after all of Abbott Laboratories operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Abbott Laboratories Competitive Analysis

The better you understand Abbott Laboratories competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Abbott Laboratories' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Abbott Laboratories' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ABTCOSTBBBYECLATAIMRKCATHDDISIBM
 1.33 
 110.54 
Abbott
 0.0344 
 553.21 
Costco
 17.29 
 24.22 
Bed Bath
 1.67 
 174.06 
Ecolab
 1.05 
 4.72 
Atai Life
 0.74 
 91.26 
Merck
 1.57 
 194.41 
Caterpillar
 0.78 
 324.84 
Home Depot
 1.66 
 122.88 
Disney
 0.23 
 136.87 
International
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Abbott Laboratories Competition Performance Charts

Complement your Abbott Laboratories position

In addition to having Abbott Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Business Supplies Thematic Idea Now

Business Supplies
Business Supplies Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Business Supplies theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Business Supplies Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Abbott Laboratories Correlation with its peers. Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.73
Market Capitalization
196 B
Quarterly Revenue Growth YOY
0.1
Return On Assets
0.0896
Return On Equity
0.24
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Abbott Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ABT
 Stock
  

USD 110.54  1.49  1.33%   

Abbott Laboratories competes with Costco Wholesale, Bed Bath, Ecolab, Atai Life, and Merck; as well as few others. The company runs under Healthcare sector within Medical Devices industry. Analyzing Abbott Laboratories competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Abbott Laboratories to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Abbott Laboratories competition on your existing holdings. Please continue to Abbott Laboratories Correlation with its peers.
  
Return on Investment is likely to drop to 14.55 in 2022. Return on Average Assets is likely to drop to 0.08 in 2022. Abbott Laboratories Revenue to Assets are comparatively stable at the moment as compared to the past year. Abbott Laboratories reported Revenue to Assets of 0.57 in 2021. Net Current Assets as percentage of Total Assets is likely to gain to 16.97 in 2022, whereas Total Assets are likely to drop slightly above 74.6 B in 2022.